These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 10874281)

  • 21. Dual determination of angiotensin-converting enzyme and angiotensin-II type 1 receptor genotypes as predictors of restenosis after coronary angioplasty.
    Hamon M; Amant C; Bauters C; Richard F; Helbecque N; Passard F; McFadden EP; Lablanche JM; Bertrand ME; Amouyel P
    Am J Cardiol; 1998 Jan; 81(1):79-81. PubMed ID: 9462611
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of platelet glycoprotein IIb/IIIa blockade with tirofiban on adverse cardiac events in patients with unstable angina or acute myocardial infarction undergoing coronary angioplasty. The RESTORE Investigators. Randomized Efficacy Study of Tirofiban for Outcomes and REstenosis.
    Circulation; 1997 Sep; 96(5):1445-53. PubMed ID: 9315530
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chemokine receptor 5 (CCR5) deletion polymorphism in North Indian patients with coronary artery disease.
    Sharda S; Gilmour A; Harris V; Singh VP; Sinha N; Tewari S; Ramesh V; Agrawal S; Mastana S
    Int J Cardiol; 2008 Feb; 124(2):254-8. PubMed ID: 17383752
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Relation of clinical presentation, stenosis morphology, and operator technique to the procedural results of rotational atherectomy and rotational atherectomy-facilitated angioplasty.
    Ellis SG; Popma JJ; Buchbinder M; Franco I; Leon MB; Kent KM; Pichard AD; Satler LF; Topol EJ; Whitlow PL
    Circulation; 1994 Feb; 89(2):882-92. PubMed ID: 8313578
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Changes in patient treatment after abrupt closure complicating percutaneous transluminal coronary angioplasty: a historic perspective.
    Danchin N; Daclin V; Juillière Y; Dibon O; Bischoff N; Pinelli G; Cuillière M; Cherrier F
    Am Heart J; 1995 Dec; 130(6):1158-63. PubMed ID: 7484763
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Incidence and clinical significance of distal embolization during primary angioplasty for acute myocardial infarction.
    Henriques JP; Zijlstra F; Ottervanger JP; de Boer MJ; van 't Hof AW; Hoorntje JC; Suryapranata H
    Eur Heart J; 2002 Jul; 23(14):1112-7. PubMed ID: 12090749
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Angiotensin II type 1 receptor gene polymorphism is associated with the severity but not prevalence of coronary artery disease.
    Surber R; Sigusch HH; Lehmann MH; Reinhardt D; Hoffmann A; Figulla HR
    Clin Genet; 2000 Sep; 58(3):237-8. PubMed ID: 11076048
    [No Abstract]   [Full Text] [Related]  

  • 28. Polymorphism of platelet glycoprotein IIb and risk of thrombosis and restenosis after coronary stent placement.
    Böttiger C; Kastrati A; Koch W; Mehilli J; von Beckerath N; Dirschinger J; Gawaz M; Schömig A
    Am J Cardiol; 1999 Nov; 84(9):987-91. PubMed ID: 10569651
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Glycoprotein Ia gene C807T polymorphism and risk for major adverse cardiac events within the first 30 days after coronary artery stenting.
    von Beckerath N; Koch W; Mehilli J; Böttiger C; Schömig A; Kastrati A
    Blood; 2000 Jun; 95(11):3297-301. PubMed ID: 10828008
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of angiotensin II type I (AT1 A1166C) receptor polymorphism in susceptibility of left ventricular dysfunction.
    Mishra A; Srivastava A; Kumar S; Mittal T; Garg N; Agarwal SK; Pande S; Mittal B
    Indian Heart J; 2015; 67(3):214-21. PubMed ID: 26138177
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association between the ACE genotype and coronary artery disease. Insights from studies on restenosis, vasomotion and thrombosis.
    Bauters C; Amouyel P
    Eur Heart J; 1998 Sep; 19 Suppl J():J24-9. PubMed ID: 9796837
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The A1166C polymorphism of the angiotensin II type-1 receptor in acute myocardial infarction.
    Araújo MA; Menezes BS; Lourenço C; Cordeiro ER; Gatti RR; Goulart LR
    Arq Bras Cardiol; 2004 Nov; 83(5):409-13; 404-8. PubMed ID: 15543360
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interaction between gene polymorphisms of renin-angiotensin system and metabolic risk factors in premature myocardial infarction.
    Petrovic D; Zorc M; Kanic V; Peterlin B
    Angiology; 2001 Apr; 52(4):247-52. PubMed ID: 11330506
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Glycoprotein Ia C807T polymorphism and risk of restenosis following coronary stenting.
    von Beckerath N; Koch W; Mehilli J; Böttiger C; Braun S; Schömig A; Kastrati A
    Atherosclerosis; 2001 Jun; 156(2):463-8. PubMed ID: 11395045
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Complementary clinical benefits of coronary-artery stenting and blockade of platelet glycoprotein IIb/IIIa receptors. Evaluation of Platelet IIb/IIIa Inhibition in Stenting Investigators.
    Lincoff AM; Califf RM; Moliterno DJ; Ellis SG; Ducas J; Kramer JH; Kleiman NS; Cohen EA; Booth JE; Sapp SK; Cabot CF; Topol EJ
    N Engl J Med; 1999 Jul; 341(5):319-27. PubMed ID: 10423466
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Gene polymorphisms of rennin-angiotensin system and coronary artery thrombosis disease].
    Zhu TN; Pan JQ; Shen ZJ; Zhao YQ; Shen T
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2004 Oct; 12(5):674-9. PubMed ID: 15498133
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The angiotensinogen gene 235T variant is associated with an increased risk of restenosis after percutaneous transluminal coronary angioplasty.
    Völzke H; Hertwig S; Rettig R; Motz W
    Clin Sci (Lond); 2000 Jul; 99(1):19-25. PubMed ID: 10887054
    [TBL] [Abstract][Full Text] [Related]  

  • 38. PAI-1 and homocysteine, but not lipoprotein (a) and thrombophilic polymorphisms, are independently associated with the occurrence of major adverse cardiac events after successful coronary stenting.
    Marcucci R; Brogi D; Sofi F; Giglioli C; Valente S; Liotta AA; Lenti M; Gori AM; Prisco D; Abbate R; Gensini GF
    Heart; 2006 Mar; 92(3):377-81. PubMed ID: 15994914
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association of angiotensin II type 1 receptor gene A1166C polymorphism with the presence of diabetes mellitus and metabolic syndrome in patients with documented coronary artery disease.
    Assali A; Ghayour-Mobarhan M; Sahebkar A; Hassani M; Kasaian J; Tatari F; Moohebati M; Paydar R; Oladi M; Esmaeili HA; Tavallaie S; Tehrani SO; Ferns GA; Behravan J
    Eur J Intern Med; 2011 Jun; 22(3):254-61. PubMed ID: 21570644
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cytochrome CYP2C19 polymorphism and risk of adverse clinical events in clopidogrel-treated patients: a meta-analysis based on 23,035 subjects.
    Mao L; Jian C; Changzhi L; Dan H; Suihua H; Wenyi T; Wei W
    Arch Cardiovasc Dis; 2013 Oct; 106(10):517-27. PubMed ID: 24080325
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.